# C. David Sjöström

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/c-david-sjostrom/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,106 |
| Field | Diabetes Treatment and Management |
| h-index | 52 |
| i10-index | 92 |
| Last Known Institution | AstraZeneca (Finland) |
| OpenAlex ID | https://openalex.org/A5041913215 |
| ORCID iD | 0000-0002-8380-9766 |
| Works | 199 |

## Researcher papers

Showing 12 of 15.

- [Dapagliflozin in Patients with Chronic Kidney Disease](https://scholariq.org/papers/dapagliflozin-in-patients-with-chronic-kidney-disease/)
- [Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects](https://scholariq.org/papers/effects-of-bariatric-surgery-on-mortality-in-swedish-obese-subjects/)
- [Bariatric Surgery and Long-term Cardiovascular Events](https://scholariq.org/papers/bariatric-surgery-and-long-term-cardiovascular-events/)
- [Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial](https://scholariq.org/papers/effects-of-bariatric-surgery-on-cancer-incidence-in-obese-patients-in-sweden/)
- [Reduction in Incidence of Diabetes, Hypertension and Lipid Disturbances after Intentional Weight Loss Induced by Bariatric Surgery: the SOS Intervention Study](https://scholariq.org/papers/reduction-in-incidence-of-diabetes-hypertension-and-lipid-disturbances-after/)
- [Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial](https://scholariq.org/papers/effects-of-dapagliflozin-on-major-adverse-kidney-and-cardiovascular-events-in/)
- [Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin](https://scholariq.org/papers/dapagliflozin-maintains-glycaemic-control-while-reducing-weight-and-body-fat/)
- [A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy](https://scholariq.org/papers/a-pre-specified-analysis-of-the-dapa-ckd-trial-demonstrates-the-effects-of/)
- [Differentiated Long-Term Effects of Intentional Weight Loss on Diabetes and Hypertension](https://scholariq.org/papers/differentiated-long-term-effects-of-intentional-weight-loss-on-diabetes-and/)
- [Clinical implementation of artificial intelligence-driven cone-beam computed tomography-guided online adaptive radiotherapy in the pelvic region](https://scholariq.org/papers/clinical-implementation-of-artificial-intelligence-driven-cone-beam-computed/)
- [Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial](https://scholariq.org/papers/effect-of-dapagliflozin-on-urinary-albumin-excretion-in-patients-with-chronic/)
- [Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial](https://scholariq.org/papers/effect-of-dapagliflozin-on-the-rate-of-decline-in-kidney-function-in-patients/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Advanced Radiotherapy Techniques](https://scholariq.org/topics/advanced-radiotherapy-techniques/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)

## Researcher university

- [AstraZeneca (Finland)](https://scholariq.org/institutions/astrazeneca-finland/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.